Healthcare provider profile · identity verified

Steven Barnes, DO

Allopathic & Osteopathic Physicians|Internal Medicine · SILVER CREEK, NY · NPI 1295758860

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Steven Barnes, DO received $243.62 in general payments during 2025 across 7 reported records.

Boston Scientific Corporation accounted for 76.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.

Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABILIFY MAINTENA as an associated drug or biological on 27924 records involving 10497 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Abilify Maintena by this doctor in 2024.

Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Nuedexta by this doctor in 2024.

Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Rexulti by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$243.62

7 reported records · 3 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Boston Scientific Corporation	Unresolved — no canonical attribution shown	$185.20	76.0%	5	2025
Impulse Dynamics (USA) Inc.	Unresolved — no canonical attribution shown	$29.33	12.0%	1	2025
Otsuka America Pharmaceutical, Inc.	Unresolved — no canonical attribution shown	$29.09	11.9%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$243.62	7

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
WATCHMAN FLX Normalized: watchman flx	Device	Boston Scientific Corporation	$185.20	5	2025
Source payment records 2025-04-02 · Boston Scientific Corporation · $89.63 · Open Payments source 2025-06-20 · Boston Scientific Corporation · $1.52 · Open Payments source 2025-06-20 · Boston Scientific Corporation · $4.14 · Open Payments source 2025-08-28 · Boston Scientific Corporation · $40.08 · Open Payments source 2025-12-07 · Boston Scientific Corporation · $49.83 · Open Payments source
Optimizer Normalized: optimizer	Device	Impulse Dynamics (USA) Inc.	$29.33	1	2025
Source payment records 2025-12-11 · Impulse Dynamics (USA) Inc. · $29.33 · Open Payments source
REXULTI Normalized: rexulti	Drug	Otsuka America Pharmaceutical, Inc.	$29.09	1	2025
Source payment records 2025-02-11 · Otsuka America Pharmaceutical, Inc. · $29.09 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
REXULTI rexulti	2025	Rexulti	2024	14 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference	2025	ABILIFY MAINTENA open payments reported associated product	CMS Open Payments — General Payments 27924 supporting records · 10497 recipient NPIs · example record 1227267721	Abilify Maintena · 2024 Exact normalized brand match · 1 Part D row	12	suppressed by CMS
Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference	2025	NUEDEXTA open payments reported associated product	CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901	Nuedexta · 2024 Exact normalized brand match · 1 Part D row	12	suppressed by CMS
Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference	2025	REXULTI open payments reported associated product	CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708	Rexulti · 2024 Exact normalized brand match · 1 Part D row	14	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1012	262
Levothyroxine Sodium	Levothyroxine Sodium	663	157
Lisinopril	Lisinopril	642	159
Metoprolol Succinate	Metoprolol Succinate	622	159
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	620	87
Amlodipine Besylate	Amlodipine Besylate	614	161
Omeprazole	Omeprazole	595	152
Gabapentin	Gabapentin	578	116
Rosuvastatin Calcium	Rosuvastatin Calcium	523	144
Eliquis	Apixaban	472	90
Pantoprazole Sodium	Pantoprazole Sodium	454	108
Furosemide	Furosemide	419	105
Metformin Hcl	Metformin Hcl	409	102
Trazodone Hcl	Trazodone Hcl	326	91
Albuterol Sulfate Hfa	Albuterol Sulfate	299	89
Potassium Chloride	Potassium Chloride	299	76
Sertraline Hcl	Sertraline Hcl	274	66
Ozempic	Semaglutide	268	47
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	264	53
Baclofen	Baclofen	260	79
Metoprolol Tartrate	Metoprolol Tartrate	241	54
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	219	39
Alendronate Sodium	Alendronate Sodium	216	50
Prednisone	Prednisone	213	112
Tamsulosin Hcl	Tamsulosin Hcl	213	64
Azithromycin	Azithromycin	210	134
Losartan Potassium	Losartan Potassium	208	58
Fluticasone Propionate	Fluticasone Propionate	204	66
Duloxetine Hcl	Duloxetine Hcl	189	46
Irbesartan	Irbesartan	182	49
Meloxicam	Meloxicam	173	48
Tramadol Hcl	Tramadol Hcl	170	54
Famotidine	Famotidine	169	47
Ibuprofen	Ibuprofen	169	49
Clopidogrel	Clopidogrel Bisulfate	164	45
Trulicity	Dulaglutide	164	27
Simvastatin	Simvastatin	163	44
Ezetimibe	Ezetimibe	162	43
Carvedilol	Carvedilol	159	41
Alprazolam	Alprazolam	150	33
Glimepiride	Glimepiride	148	42
Donepezil Hcl	Donepezil Hcl	138	48
Bumetanide	Bumetanide	134	43
Zolpidem Tartrate	Zolpidem Tartrate	133	23
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	131	40
Xarelto	Rivaroxaban	129	28
Allopurinol	Allopurinol	128	34
Oxycodone Hcl	Oxycodone Hcl	128	37
Pravastatin Sodium	Pravastatin Sodium	124	32
Spironolactone	Spironolactone	120	33
Warfarin Sodium	Warfarin Sodium	118	17
Tizanidine Hcl	Tizanidine Hcl	116	19
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	116	25
Pregabalin	Pregabalin	112	17
Triamcinolone Acetonide	Triamcinolone Acetonide	112	52
Hydrochlorothiazide	Hydrochlorothiazide	111	34
Quetiapine Fumarate	Quetiapine Fumarate	111	18
Hydroxyzine Hcl	Hydroxyzine Hcl	105	22
Venlafaxine Hcl Er	Venlafaxine Hcl	105	21
Escitalopram Oxalate	Escitalopram Oxalate	104	48
Atenolol	Atenolol	100	29
Fluoxetine Hcl	Fluoxetine Hcl	100	24
Myrbetriq	Mirabegron	94	16
Celecoxib	Celecoxib	93	30
Mirtazapine	Mirtazapine	92	24
Clonidine Hcl	Clonidine Hcl	91	24
Oxybutynin Chloride Er	Oxybutynin Chloride	90	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	23
Jardiance	Empagliflozin	88	27
Diazepam	Diazepam	87	15
Citalopram Hbr	Citalopram Hydrobromide	84	23
Lovastatin	Lovastatin	83	17
Clonazepam	Clonazepam	81	17
Nystatin	Nystatin	80	39
Humalog Kwikpen U-100	Insulin Lispro	76	18
Atropine Sulfate	Atropine Sulfate	75	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	75	20
Insulin Lispro Kwikpen U-100	Insulin Lispro	74	18
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	74	41
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	71	15
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	70	13
Farxiga	Dapagliflozin Propanediol	70	16
Fenofibrate	Fenofibrate,micronized	70	17
Meclizine Hcl	Meclizine Hcl	70	22
Mounjaro	Tirzepatide	69	suppressed
Ondansetron Hcl	Ondansetron Hcl	67	37
Amoxicillin	Amoxicillin	65	45
Aripiprazole	Aripiprazole	65	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	65	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	62	18
Cephalexin	Cephalexin	61	46
Levetiracetam	Levetiracetam	61	15
Nifedipine Er	Nifedipine	61	13
Lidocaine	Lidocaine	59	suppressed
Naproxen	Naproxen	59	14
Paroxetine Hcl	Paroxetine Hcl	58	14
Montelukast Sodium	Montelukast Sodium	57	18
Metformin Hcl Er	Metformin Hcl	56	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	55	47
Levofloxacin	Levofloxacin	55	36
Buspirone Hcl	Buspirone Hcl	52	13
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	52	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	51	suppressed
Januvia	Sitagliptin Phosphate	51	suppressed
Divalproex Sodium	Divalproex Sodium	50	12
Memantine Hcl	Memantine Hcl	50	12
Valsartan	Valsartan	50	14
Droplet Pen Needle	Pen Needle, Diabetic	48	16
Hydralazine Hcl	Hydralazine Hcl	47	15
Topiramate	Topiramate	47	suppressed
Fenofibrate	Fenofibrate	46	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	46	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	45	11
Fenofibrate	Fenofibrate Nanocrystallized	45	suppressed
Cholestyramine	Cholestyramine (With Sugar)	44	11
Fluconazole	Fluconazole	44	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	12
Lamotrigine	Lamotrigine	43	suppressed
Tadalafil	Tadalafil	43	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	35
Amitriptyline Hcl	Amitriptyline Hcl	41	11
Bupropion Xl	Bupropion Hcl	41	15
Labetalol Hcl	Labetalol Hcl	41	suppressed
Synthroid	Levothyroxine Sodium	41	11
Lorazepam	Lorazepam	40	27
Midodrine Hcl	Midodrine Hcl	40	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	38	28
Finasteride	Finasteride	37	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	37	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	37	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	36	suppressed
Lactulose	Lactulose	36	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	36	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	36	suppressed
Ammonium Lactate	Ammonium Lactate	35	18
Benazepril Hcl	Benazepril Hcl	35	11
Olmesartan Medoxomil	Olmesartan Medoxomil	35	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	33	suppressed
Chlorzoxazone	Chlorzoxazone	33	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	32	13
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	32	suppressed
Doxepin Hcl	Doxepin Hcl	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	11
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	32	suppressed
Ondansetron Odt	Ondansetron	31	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Entresto	Sacubitril/Valsartan	30	suppressed
Morphine Sulfate Er	Morphine Sulfate	30	suppressed
Sucralfate	Sucralfate	30	suppressed
Amiodarone Hcl	Amiodarone Hcl	29	suppressed
Hydrocortisone	Hydrocortisone	29	12
Novolog Flexpen	Insulin Aspart	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	28	suppressed
Austedo Xr	Deutetrabenazine	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	16
Gemtesa	Vibegron	27	suppressed
Lidocaine Hcl	Lidocaine Hcl	27	24
Doxycycline Hyclate	Doxycycline Hyclate	26	19
Folic Acid	Folic Acid	26	suppressed
Lubiprostone	Lubiprostone	26	suppressed
Primidone	Primidone	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Carbamazepine	Carbamazepine	25	suppressed
Glipizide	Glipizide	25	suppressed
Icosapent Ethyl	Icosapent Ethyl	25	suppressed
Ketoconazole	Ketoconazole	25	suppressed
Mupirocin	Mupirocin	25	20
Paxlovid	Nirmatrelvir/Ritonavir	25	25
Lansoprazole	Lansoprazole	24	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	23	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Cefuroxime	Cefuroxime Axetil	22	14
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	22	suppressed
Colestipol Hcl	Colestipol Hcl	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	22	20
Haloperidol Lactate	Haloperidol Lactate	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Repatha Sureclick	Evolocumab	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Trimethoprim	Trimethoprim	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Unifine Pentips	Pen Needle, Diabetic	21	suppressed
Ceftriaxone	Ceftriaxone Sodium	20	17
Latanoprost	Latanoprost	20	suppressed
Xifaxan	Rifaximin	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Flecainide Acetate	Flecainide Acetate	19	suppressed
Nitroglycerin	Nitroglycerin	19	15
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Clindamycin Hcl	Clindamycin Hcl	18	16
Colchicine	Colchicine	18	11
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Lyrica	Pregabalin	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Olanzapine	Olanzapine	18	suppressed
Ranolazine Er	Ranolazine	18	suppressed
Roflumilast	Roflumilast	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	18	suppressed
Cefdinir	Cefdinir	17	14
Quetiapine Fumarate Er	Quetiapine Fumarate	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Sildenafil Citrate	Sildenafil Citrate	17	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	17	suppressed
Constulose	Lactulose	16	suppressed
Invokana	Canagliflozin	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Nyamyc	Nystatin	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Rivastigmine	Rivastigmine	16	suppressed
Brilinta	Ticagrelor	15	suppressed
Enulose	Lactulose	15	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	15	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	15	suppressed
Methylprednisolone	Methylprednisolone	15	12
Wegovy	Semaglutide	15	suppressed
Clonidine	Clonidine	14	suppressed
Linzess	Linaclotide	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Rexulti	Brexpiprazole	14	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	13	13
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Abilify Maintena	Aripiprazole	12	suppressed
Atrovent Hfa	Ipratropium Bromide	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Erythromycin	Erythromycin Base	12	suppressed
Estradiol (Once Weekly)	Estradiol	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Armour Thyroid	Thyroid,pork	11	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Lurasidone Hcl	Lurasidone Hcl	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nystop	Nystatin	11	suppressed
Timolol Maleate	Timolol Maleate	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$243.62 · 7 records	Boston Scientific Corporation	Optimizer, REXULTI, WATCHMAN FLX	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Rexulti play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error